Two Most Common BPH 5-ARI Combo Treatments Equally Effective, Economical
News
There is no difference in outcomes among men with benign prostatic hyperplasia (BPH) treated early with two different 5-alpha reductase inhibitors (5-ARIs) in combination with alpha-blockers, according to a study ... Read more